- Home
- JNVR vs SILO Comparison
JNVR vs SILO Comparison
Compare JNVR & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNVR
- SILO
- Stock Information
- Founded
- JNVR 2018
- SILO 2010
- Country
- JNVR United States
- SILO United States
- Employees
- JNVR N/A
- SILO N/A
- Industry
- JNVR Finance: Consumer Services
- SILO Apparel
- Sector
- JNVR Finance
- SILO Consumer Discretionary
- Exchange
- JNVR Nasdaq
- SILO Nasdaq
- Market Cap
- JNVR 5.4M
- SILO 8.8M
- IPO Year
- JNVR 2023
- SILO N/A
- Fundamental
- Price
- JNVR $4.68
- SILO $1.32
- Analyst Decision
- JNVR
- SILO
- Analyst Count
- JNVR 0
- SILO 0
- Target Price
- JNVR N/A
- SILO N/A
- AVG Volume (30 Days)
- JNVR 5.1K
- SILO 116.2K
- Earning Date
- JNVR 03-13-2025
- SILO 03-18-2025
- Dividend Yield
- JNVR N/A
- SILO N/A
- EPS Growth
- JNVR N/A
- SILO N/A
- EPS
- JNVR N/A
- SILO N/A
- Revenue
- JNVR $2,099,660.00
- SILO $72,102.00
- Revenue This Year
- JNVR N/A
- SILO $1.86
- Revenue Next Year
- JNVR N/A
- SILO N/A
- P/E Ratio
- JNVR N/A
- SILO N/A
- Revenue Growth
- JNVR 4.82
- SILO N/A
- 52 Week Low
- JNVR $3.37
- SILO $0.77
- 52 Week High
- JNVR $11.84
- SILO $4.50
- Technical
- Relative Strength Index (RSI)
- JNVR 52.77
- SILO 45.03
- Support Level
- JNVR $3.86
- SILO $1.21
- Resistance Level
- JNVR $4.29
- SILO $1.34
- Average True Range (ATR)
- JNVR 0.34
- SILO 0.11
- MACD
- JNVR 0.08
- SILO 0.00
- Stochastic Oscillator
- JNVR 85.18
- SILO 41.38
Stock Price Comparison Chart: JNVR vs SILO
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.